1,797
Views
0
CrossRef citations to date
0
Altmetric
Report

Interplay of heavy chain introns influences efficient transcript splicing and affects product quality of recombinant biotherapeutic antibodies from CHO cells

, , , , &
Article: 2242548 | Received 12 Apr 2023, Accepted 26 Jul 2023, Published online: 09 Aug 2023

References

  • Walsh G, Walsh E. Biopharmaceutical benchmarks 2022. Nat Biotechnol. 2022;40(12):1722–14. doi:10.1038/s41587-022-01582-x.
  • Lamanna WC, Holzmann J, Cohen HP, Guo X, Schweigler M, Stangler T, Seidl A, Schiestl M. Maintaining consistent quality and clinical performance of biopharmaceuticals. Expert Opin Biol Ther. 2018;18(4):369–79. doi:10.1080/14712598.2018.1421169.
  • Goetze AM, Schenauer MR, Flynn GC. Assessing monoclonal antibody product quality attribute criticality through clinical studies. MAbs. 2010;2(5):500–07. doi:10.4161/mabs.2.5.12897.
  • Alt N, Zhang TY, Motchnik P, Taticek R, Quarmby V, Schlothauer T, Beck H, Emrich T, Harris RJ. Determination of critical quality attributes for monoclonal antibodies using quality by design principles. Biologicals. 2016;44(5):291–305. doi:10.1016/j.biologicals.2016.06.005.
  • Wei Z, Feng J, Lin HY, Mullapudi S, Bishop E, Tous GI, Casas-Finet J, Hakki F, Strouse R, Schenerman MA. Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. Anal Chem. 2007;79(7):2797–805. doi:10.1021/ac062311j.
  • Luo Y, Lu Z, Raso SW, Entrican C, Tangarone B. Dimers and multimers of monoclonal IgG1 exhibit higher in vitro binding affinities to Fcγ receptors. MAbs. 2009;1(5):491–504. doi:10.4161/mabs.1.5.9631.
  • Shaul O. How introns enhance gene expression. Int J Biochem Cell Biol. 2017;91:145–55. doi:10.1016/j.biocel.2017.06.016.
  • Spahr CS, Daris ME, Graham KC, Soriano BD, Stevens JL, Shi SDH. Discovery, characterization, and remediation of a C-terminal Fc-extension in proteins expressed in CHO cells. MAbs. 2018;10(8):1291–300. doi:10.1080/19420862.2018.1511197.
  • Harris C, Xu W, Grassi L, Wang C, Markle A, Hardman C, Stevens R, Miro-Quesada G, Hatton D, Wang J. Identification and characterization of an IgG sequence variant with an 11 kDa heavy chain C-terminal extension using a combination of mass spectrometry and high-throughput sequencing analysis. MAbs. 2019;11(8):1452–63. doi:10.1080/19420862.2019.1667740.
  • Delmar JA, Harris C, Grassi L, Macapagal N, Wang J, Hatton D, Xu W. Monoclonal antibody sequence variants disguised as fragments: identification, characterization, and their removal by purification process optimization. J Pharm Sci. 2022;111(11):3009–16. doi:10.1016/j.xphs.2022.08.002.
  • Choi T, Huang M, Gorman C, Jaenisch1 R. A generic intron increases gene expression in transgenic mice. Mol Cell Biol. 1991;11(6):3070–74. doi:10.1128/MCB.11.6.3070.
  • Shabalina SA, Ogurtsov AY, Spiridonov AN, Novichkov PS, Spiridonov NA, Koonin EV. Distinct patterns of expression and evolution of intronless and intron-containing mammalian genes. Mol Biol Evol. 2010;27(8):1745–49. doi:10.1093/molbev/msq086.
  • Xu DH, Wang XY, Jia YL, Wang TY, Tian ZW, Feng X, Zhang YN. SV40 intron, a potent strong intron element that effectively increases transgene expression in transfected Chinese hamster ovary cells. J Cell Mol Med. 2018;22(4):2231. doi:10.1111/jcmm.13504.
  • Buchman AR, Berg P. Comparison of intron-dependent and intron-independent gene expression. Mol Cell Biol. 1988;8(10):4395–405. doi:10.1128/MCB.8.10.4395.
  • Palmiter RD, Sandgren EP, Avarbock MR, Diane Allen D, Brinster RL. Heterologous introns can enhance expression of transgenes in mice. Proc Natl Acad Sci U S A. 1991;88(2):478–82. doi:10.1073/pnas.88.2.478.
  • Agarwal N, Ansari A, Copenhaver GP. Enhancement of transcription by a splicing-competent intron is dependent on promoter directionality. PLoS Genet. 2016;12(5):12. doi:10.1371/journal.pgen.1006047.
  • Beaulieu E, Green L, Elsby L, Alourfi Z, Morand EF, Ray DW, Donn R. Identification of a novel cell type-specific intronic enhancer of macrophage migration inhibitory factor (MIF) and its regulation by mithramycin. Clin Exp Immunol. 2011;163(2):178–88. doi:10.1111/j.1365-2249.2010.04289.x.
  • Kolasinska-Zwierz P, Down T, Latorre I, Liu T, Liu XS, Ahringer J. Differential chromatin marking of introns and expressed exons by H3K36me3. Nat Genet. 2009;41(3):376–81. doi:10.1038/ng.322.
  • Tilgner H, Nikolaou C, Althammer S, Sammeth M, Beato M, Valcárcel J, Guigó R. Nucleosome positioning as a determinant of exon recognition. Nature Structural & Molecular Biology. 2009;16(9):996–1001. doi:10.1038/nsmb.1658.
  • Millevoi S, Loulergue C, Dettwiler S, Karaa SZ, Keller W, Antoniou M, Vagner S. An interaction between U2AF 65 and CF Im links the splicing and 3′ end processing machineries. Embo J. 2006;25(20):4854–64. doi:10.1038/sj.emboj.7601331.
  • Valencia P, Dias AP, Reed R. Splicing promotes rapid and efficient mRNA export in mammalian cells. Proc Natl Acad Sci U S A. 2008;105(9):3386–91. doi:10.1073/pnas.0800250105.
  • Oganesyan V, Gao C, Shirinian L, Wu H, Dall’acqua WF. Structural characterization of a human Fc fragment engineered for lack of effector functions. Acta Crystallogr D Biol Crystallogr. 2008;64(6):700–04. doi:10.1107/S0907444908007877.
  • Pertea M, Lin X, Salzberg SL. GeneSplicer: A new computational method for splice site prediction. Nucleic Acids Res. 2001;29(5):1185–90. doi:10.1093/nar/29.5.1185.
  • Persic L, Roberts A, Wilton J, Cattaneo A, Bradbury A, Hoogenboom HR. An integrated vector system for the eukaryotic expression of antibodies or their fragments after selection from phage display libraries. Gene. 1997;187(1):9–18. doi:10.1016/S0378-1119(96)00628-2.
  • Clancy S. RNA splicing | learn science at scitable. Nat Educ. 2008;1(1): 31. https://www.nature.com/scitable/topicpage/rna-splicing-introns-exons-and-spliceosome-12375/.
  • Bruce SR, Kaetzel CS, Peterson ML. Cryptic intron activation within the large exon of the mouse polymeric immunoglobulin receptor gene: cryptic splice sites correspond to protein domain boundaries. Nucleic Acids Res. 1999;27(17):3446–54. doi:10.1093/nar/27.17.3446.
  • Dominski Z, Kole R. Cooperation of pre-mRNA sequence elements in splice site selection. Mol Cell Biol. 1992;12(5):2108–14. doi:10.1128/MCB.12.5.2108.
  • Liu H, Chumsae C, Gaza-Bulseco G, Hurkmans K, Radziejewski CH. Ranking the susceptibility of disulfide bonds in human IgG1 antibodies by reduction, differential alkylation, and LC−MS analysis. Anal Chem. 2010;82(12):5219–26. doi:10.1021/ac100575n.
  • Zhang Q, Schenauer MR, McCarter JD, Flynn GC. IgG1 thioether bond formation in vivo. J Biol Chem. 2013;288(23):16371–82. doi:10.1074/jbc.M113.468397.
  • Stoyle CL, Stephens PE, Humphreys DP, Heywood S, Cain K, Bulleid NJ. IgG light chain-independent secretion of heavy chain dimers: consequence for therapeutic antibody production and design. Biochem J. 2017;474(18):3179–88. doi:10.1042/BCJ20170342.
  • Kim SW, Taggart AJ, Heintzelman C, Cygan KJ, Hull CG, Wang J, Shrestha B, Fairbrother WG. Widespread intra-dependencies in the removal of introns from human transcripts. Nucleic Acids Res. 2017;45(16):9503–13. doi:10.1093/nar/gkx661.
  • Murray JI, Voelker RB, Henscheid KL, Warf MB, Berglund JA. Identification of motifs that function in the splicing of non-canonical introns. Genome Biol. 2008;9(6):R97. doi:10.1186/gb-2008-9-6-r97.
  • Berglund JA, Abovich N, Rosbash M. A cooperative interaction between U2AF65 and mBBP/SF1 facilitates branchpoint region recognition. Genes Dev. 1998;12(6):858–67. doi:10.1101/gad.12.6.858.
  • Lefranc M-P, Lefranc G. Immunoglobulins or antibodies: IMGT® Bridging genes, structures and functions. Biomedicines. 2020;8(9):8. doi:10.3390/biomedicines8090319.
  • Watakabe A, Tanaka K, Shimura Y. The role of exon sequences in splice site selection. Genes Dev. 1993;7(3):407–18. doi:10.1101/gad.7.3.407.
  • Zheng Z-M. Regulation of alternative RNA splicing by exon definition and exon sequences in viral and mammalian gene expression. J Biomed Sci. 2004;11(3):278–94. doi:10.1007/BF02254432.
  • Schlatter S, Stansfield SH, Dinnis DM, Racher AJ, Birch JR, James DC. On the optimal ratio of heavy to light chain genes for efficient recombinant antibody production by CHO cells. Biotechnol Prog. 2005;21(1):122–33. doi:10.1021/bp049780w.